Ebersbach; Hilmar Erhard

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ebersbach; Hilmar Erhard.The latest application filed is for "treatment of cancer using humanized anti-bcma chimeric antigen receptor".

Company Profile

5.5.13

Ebersbach; Hilmar Erhard - Basel CH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Treatment Of Cancer Using Humanized Anti-bcma Chimeric Antigen Receptor App 20220064316 - Brogdon; Jennifer ; et al.	2022-03-03
Anti-BCMA chimeric antigen receptor Grant 11,084,880 - Brogdon , et al. August 10, 2	2021-08-10
Treatment Of Cancer Using A Cd33 Chimeric Antigen Receptor App 20210139595 - Ebersbach; Hilmar Erhard ; et al.	2021-05-13
Treatment of cancer using a CD33 chimeric antigen receptor Grant 10,851,166 - Ebersbach , et al. December 1, 2	2020-12-01
Treatment Of Cancer Using A Cll-1 Chimeric Antigen Receptor App 20200215171 - Brogdon; Jennifer ; et al.	2020-07-09
Treatment of cancer using a CLL-1 chimeric antigen receptor Grant 10,568,947 - Brogdon , et al. Feb	2020-02-25
Treatment Of Cancer Using 5 Humanized Anti-bcma Chimeric Antigen Receptor App 20190153061 - Brogdon; Jennifer ; et al.	2019-05-23
Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor Grant 10,174,095 - Brogdon , et al. J	2019-01-08
Phosphoglycerate Kinase 1 (pgk) Promoters And Methods Of Use For Expressing Chimeric Antigen Receptor App 20180118834 - Brogdon; Jennifer ; et al.	2018-05-03
Treatment Of Cancer Using A Cd33 Chimeric Antigen Receptor App 20180044423 - Ebersbach; Hilmar Erhard ; et al.	2018-02-15
Treatment of cancer using a CD33 chimeric antigen receptor Grant 9,777,061 - Ebersbach , et al. October 3, 2	2017-10-03
Treatment Of Cancer Using A Cd33 Chimeric Antigen Receptor App 20160096892 - Brogdon; Jennifer ; et al.	2016-04-07
Treatment Of Cancer Using A Cll-1 Chimeric Antigen Receptor App 20160051651 - Brogdon; Jennifer ; et al.	2016-02-25
Treatment Of Cancer Using Humanized Anti-bcma Chimeric Antigen Receptor App 20160046724 - Brogdon; Jennifer ; et al.	2016-02-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.